← Back

Clinical trials for advancing innovative interventions for neurodegenerative diseases

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. The scientific and clinical communities benefit from the exchange of data, knowledge and best practices, thereby strengthening their collaboration in the EU, the Associated Countries and beyond.

Amount
up to €10M
Type
Program

Key facts

Key facts for Clinical trials for advancing innovative interventions for neurodegenerative diseases
Amountup to €10M — €39.3M shared across the programme
IssuerHorizon Europe
Who can applySee eligibility details
SectorsAI/ML · HealthTech
DeadlineCloses 17 Feb 2027

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: ec.europa.eu ↗

Source checked 11 hours ago

  1. 10 days agoagentImported from the official source